Article(id=1329835603128070915, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835512791150603, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.11.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1674921600000, receivedDateStr=2023-01-29, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987114936, onlineDateStr=2026-11-18, pubDate=1699545600000, pubDateStr=2023-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987114936, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987114936, creator=13701087609, updateTime=1794987114936, updator=13701087609, issue=Issue{id=1329835512791150603, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='11', pageStart='1133', pageEnd='1242', issueExtLink='null', onlineDate='null', pubDate='1699545600000', pubDateStr='2023-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794987093398, creator='13701087609', updateTime=1794988063154, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839580662051474, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835512791150603, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839580662051475, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835512791150603, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1219, endPage=1225, ext={EN=ArticleExt(id=1329835603329397508, articleId=1329835603128070915, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of polyinosinic polycytidylic acid in immunopreparations, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Polyinosinic polycytidylic acid is an artificially synthesized double stranded ribonucleic acid that is recognized by Toll-like receptor 3, induces innate and adaptive immune responses. It is generally considered as a type Ⅰinterferon inducer, antiviral and anti-tumor immunomodulator agent, and also an effective vaccine adjuvant, and has shown great potential in the treatment of diseases. Therefore, this article reviewed the regulatory mechanism, safety, and the research progress of polyinosinic polycytidylic acid as an immunologic agent in clinical practice, hoping to provide useful reference for the follow-up research of polyinosinic polycytidylic acid.

, authors=Dingxin KE, Yi WANG, Min SUN, Yajun JIANG, Kaiyun LIU*, authorsList=Dingxin KE, Yi WANG, Min SUN, Yajun JIANG, Kaiyun LIU, authorCompany=null, correspAuthors=Kaiyun LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835603585250053, articleId=1329835603128070915, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=聚肌胞苷酸在免疫制剂中的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

聚肌胞苷酸是一种人工合成的双链核糖核酸,可被Toll样受体3识别,诱导先天和适应性免疫反应,其通常被认为是一种Ⅰ型干扰素诱导剂、抗病毒和抗肿瘤等免疫调节剂,也是有效的疫苗佐剂,并在疾病治疗中展现出巨大的潜力。因此该文从聚肌胞苷酸的作用机制、安全性及在临床中作为免疫制剂的研究进展等方面进行综述,希望能为其的后续研究提供有益参考。

, authors=柯丁心, 王毅, 孙敏, 蒋亚君, 刘开云*, authorsList=柯丁心, 王毅, 孙敏, 蒋亚君, 刘开云, authorCompany=null, correspAuthors=刘开云, authorNote=

柯丁心,助理实验师,研究方向:幽门螺杆菌疫苗的研究。

, correspAuthorsNote=
刘开云,副教授,研究方向:细菌感染免疫机制与创新疫苗研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=uvpxdQ62dlPwXV3b6UBeQw==, magXml=kRUArDvDTLNWJg+OUqII1w==, pdfUrl=null, pdf=+yrclCGauEK7aL7i21poFQ==, pdfFileSize=1742085, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=vDopIl33nTYRs74kuPXgpQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329835603983708938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835604059206412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835603983708938, language=EN, stringName=Dingxin KE, firstName=Dingxin, middleName=null, lastName=KE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835604151481101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835603983708938, language=CN, stringName=柯丁心, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio={"content":"

柯丁心,助理实验师,研究方向:幽门螺杆菌疫苗的研究。

"}, bioImg=null, bioContent=

柯丁心,助理实验师,研究方向:幽门螺杆菌疫苗的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835604239561487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835604344419089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835604239561487, language=EN, stringName=Yi WANG, firstName=Yi, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835604419916562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835604239561487, language=CN, stringName=王毅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835606068278036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835606181524246, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606068278036, language=EN, stringName=Min SUN, firstName=Min, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835606311547671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606068278036, language=CN, stringName=孙敏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835606387045145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835606504485659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606387045145, language=EN, stringName=Yajun JIANG, firstName=Yajun, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835606592566044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606387045145, language=CN, stringName=蒋亚君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835606672257822, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835606747755296, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606672257822, language=EN, stringName=Kaiyun LIU, firstName=Kaiyun, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835606840029985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606672257822, language=CN, stringName=刘开云, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])])], keywords=[Keyword(id=1329835606928110370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=EN, orderNo=1, keyword=polyinosinic polycytidylic acid), Keyword(id=1329835607011996451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=EN, orderNo=2, keyword=Toll-like receptor 3), Keyword(id=1329835607083299620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=EN, orderNo=3, keyword=immunotherapy), Keyword(id=1329835607154602789, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=EN, orderNo=4, keyword=vaccine adjuvant), Keyword(id=1329835607217517350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=CN, orderNo=1, keyword=聚肌胞苷酸), Keyword(id=1329835607276237607, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=CN, orderNo=2, keyword=Toll样受体3), Keyword(id=1329835607347540776, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=CN, orderNo=3, keyword=免疫治疗), Keyword(id=1329835607414649641, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, language=CN, orderNo=4, keyword=疫苗佐剂)], refs=[Reference(id=1329835607595004715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Field AK, Tytell AA, Lampson GP, et al. Inducers of interferon and host resistance. Ⅱ. Multistranded synthetic polynucleotide complexes[J]. Proc Natl Acad Sci U S A, 1967, 58(3): 1004-1010., articleTitle=null, refAbstract=null), Reference(id=1329835607662113580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Hong Y, Lee J, Vu TH, et al. Immunomodulatory effects of poly (I: C)-stimulated exosomes derived from chicken macrophages[J]. Poult Sci, 2021, 100(8): 101247., articleTitle=null, refAbstract=null), Reference(id=1329835607754388269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Haddad FL, Patel SV, Schmid S. Maternal immune activation by polyI: C as a preclinical model for neurodevelopmental disorders: a focus on autism and schizophrenia[J]. Neurosci Biobehav Rev, 2020, 113: 546-567., articleTitle=null, refAbstract=null), Reference(id=1329835607825691438, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen Y, Lin J, Zhao Y, et al. Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses[J]. J Zhejiang Univ Sci B, 2021, 22(8): 609-632., articleTitle=null, refAbstract=null), Reference(id=1329835607892800303, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Hafner AM, Corthesy B, Merkle HP. Particulate formulations for the delivery of poly (I: C) as vaccine adjuvant[J]. Adv Drug Deliv Rev, 2013, 65(10): 1386-1399., articleTitle=null, refAbstract=null), Reference(id=1329835607964103472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu M, Levine SJ. Toll-like receptor, RIG-Ⅰ-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses[J]. Cytokine Growth Factor Rev, 2011, 22(2): 63-72., articleTitle=null, refAbstract=null), Reference(id=1329835611466347313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination[J]. Nat Rev Immunol, 2012, 12(7): 479-491., articleTitle=null, refAbstract=null), Reference(id=1329835611554427698, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Sultan H, Salazar AM, Celis E. Poly-ICLC, a multi-functional immune modulator for treating cancer[J]. Semin Immunol, 2020, 49: 101414., articleTitle=null, refAbstract=null), Reference(id=1329835611650896691, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Mori H, Murakami M, Tsuda T, et al. Reduced-HMGB1 suppresses poly (I: C)-induced inflammation in keratinocytes[J]. J Dermatol Sci, 2018, 90(2): 154-165., articleTitle=null, refAbstract=null), Reference(id=1329835611755754292, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=De Waele J, Verhezen T, van der Heijden S, et al. A systematic review on poly (I: C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy[J]. J Exp Clin Cancer Res, 2021, 40(1): 213., articleTitle=null, refAbstract=null), Reference(id=1329835611835446069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Komal A, Noreen M, El-Kott AF. TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review[J]. Immunol Res, 2021, 69(4): 312-322., articleTitle=null, refAbstract=null), Reference(id=1329835611936109366, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Gitlin L, Barchet W, Gilfillan S, et al. Essential role of MDA-5 in type Ⅰ IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus[J]. Proc Natl Acad Sci U S A, 2006, 103(22): 8459-8464., articleTitle=null, refAbstract=null), Reference(id=1329835612015801143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Sultan H, Wu J, Fesenkova VI, et al. Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration[J]. J Immunother Cancer, 2020, 8(2): e001224., articleTitle=null, refAbstract=null), Reference(id=1329835612108075832, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Fučíková J, Rožková D, Ulčová H, et al. PolyI: C-activated dendritic cells that were generated in Cellgro for use in cancer immunotherapy trials[J]. J Transl Med, 2011, 9: 223., articleTitle=null, refAbstract=null), Reference(id=1329835612221322041, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation[J]. J Clin Investigation, 2007, 117(5): 1119-1127., articleTitle=null, refAbstract=null), Reference(id=1329835612284236602, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Sultan H, Wu J, Kumai T, et al. Role of MDA5 and interferon-Ⅰ in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice[J]. Cancer Immunol Immunother, 2018, 67(7): 1091-1103., articleTitle=null, refAbstract=null), Reference(id=1329835612380705595, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Plote D, Choi W, Mokkapati S, et al. Inhibition of urothelial carcinoma through targeted type Ⅰ interferon-mediated immune activation[J]. Oncoimmunology, 2019, 8(5): e1577125., articleTitle=null, refAbstract=null), Reference(id=1329835612464591676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Anfray C, Mainini F, Digifico E, et al. Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity[J]. J Immunother Cancer, 2021, 9(9): e002408., articleTitle=null, refAbstract=null), Reference(id=1329835612640752445, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Le Naour J, Galluzzi L, Zitvogel L, et al. Trial watch: TLR3 agonists in cancer therapy[J]. Oncoimmunology, 2020, 9(1): 1771143., articleTitle=null, refAbstract=null), Reference(id=1329835612728832830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Matsumoto M, Takeda Y, Seya T. Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy[J]. Expert Opin Biol Ther, 2020, 20(8): 937-946., articleTitle=null, refAbstract=null), Reference(id=1329835612821107519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Martins KAO, Bavari S, Salazar AM. Vaccine adjuvant uses of poly-IC and derivatives[J]. Expert Rev Vaccines, 2015, 14(3): 447-459., articleTitle=null, refAbstract=null), Reference(id=1329835612921770816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Kato H, Takeuchi O, Mikamo-Satoh E, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-Ⅰ and melanoma differentiation-associated gene 5[J]. J Exp Med, 2008, 205(7): 1601-1610., articleTitle=null, refAbstract=null), Reference(id=1329835612988879681, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Bumcrot D, Manoharan M, Koteliansky V, et al. RNAi therapeutics: a potential new class of pharmaceutical drugs[J]. Nat Chem Biol, 2006, 2(12): 711-719., articleTitle=null, refAbstract=null), Reference(id=1329835613068571458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Aranda F, Vacchelli E, Obrist F, et al. Trial watch: Toll-like receptor agonists in oncological indications[J]. Oncoimmunology, 2014, 3: e29179., articleTitle=null, refAbstract=null), Reference(id=1329835613139874627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Krown SE, Kerr D, Stewart WE, et al. Phase Ⅰ trials of poly (I, C) complexes in advanced cancer[J]. J Biol Response Mod, 1985, 4(6): 640-649., articleTitle=null, refAbstract=null), Reference(id=1329835613202789188, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Ko KH, Cha SB, Lee SH, et al. A novel defined TLR3 agonist as an effective vaccine adjuvant[J]. Front Immunol, 2023, 14: 1075291., articleTitle=null, refAbstract=null), Reference(id=1329835613261509445, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Ammi R, de Waele J, Willemen Y, et al. Poly (I: C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs[J]. Pharmacol Ther, 2015, 146: 120-131., articleTitle=null, refAbstract=null), Reference(id=1329835614884705094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Chin AI, Miyahira AK, Covarrubias A, et al. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance[J]. Cancer Res, 2010, 70(7): 2595-2603., articleTitle=null, refAbstract=null), Reference(id=1329835615027311431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Kawai T, Akira S. Toll-like receptor and RIG-Ⅰ-like receptor signaling[J]. Ann N Y Acad Sci, 2008, 1143: 1-20., articleTitle=null, refAbstract=null), Reference(id=1329835615132169032, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Besch R, Poeck H, Hohenauer T, et al. Proapoptotic signaling induced by RIG-Ⅰ and MDA-5 results in type Ⅰ interferon-independent apoptosis in human melanoma cells[J]. J Clinical Investigation, 2009, 119(8): 2399-2411., articleTitle=null, refAbstract=null), Reference(id=1329835615211860809, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Guinn ZP, Petro TM. IFN-γ synergism with poly I: C reduces growth of murine and human cancer cells with simultaneous changes in cell cycle and immune checkpoint proteins[J]. Cancer Lett, 2018, 438: 1-9., articleTitle=null, refAbstract=null), Reference(id=1329835615316718410, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Zheng X, Li S, Yang H. Roles of Toll-like receptor 3 in human tumors[J]. Front Immunol, 2021, 12: 667454., articleTitle=null, refAbstract=null), Reference(id=1329835615392215883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=TIssari J, Sirén J, Meri S, et al. IFN-α enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression[J]. J Immunol, 2005, 174(7): 4289-4294., articleTitle=null, refAbstract=null), Reference(id=1329835615467713356, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-Ⅰ has an essential function in double-stranded RNA-induced innate antiviral responses[J]. Nat Immunol, 2004, 5(7): 730-737., articleTitle=null, refAbstract=null), Reference(id=1329835615543210829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Aznar MA, Planelles L, Perez-Olivares M, et al. Immunotherapeutic effects of intratumoral nanoplexed poly I: C[J]. J Immunother Cancer, 2019, 7(1): 116., articleTitle=null, refAbstract=null), Reference(id=1329835615606125390, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Márquez-Rodas I, Longo F, Rodriguez-Ruiz ME, et al. Intratumoral nanoplexed poly I: C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors[J]. Sci Transl Med, 2020, 12(565): eabb0391., articleTitle=null, refAbstract=null), Reference(id=1329835615669039951, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Penza V, Russell S, Schulze AJ. The long-lasting enigma of polycytidine (polyC) tract[J]. PLoS Pathog, 2021, 17(8): e1009739., articleTitle=null, refAbstract=null), Reference(id=1329835615731954512, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu X, Meng L, Chen L, et al. IL-6 expression promoted by poly (I: C) in cervical cancer cells regulates cytokine expression and recruitment of macrophages[J]. J Cell Mol Med, 2020, 24(3): 2284-2293., articleTitle=null, refAbstract=null), Reference(id=1329835615799063377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Jiang X, Guan S, Qiao Y, et al. Effects of poly (I: C) and MF59 co-adjuvants on immunogenicity and efficacy of survivin polypeptide immunogen against melanoma[J]. J Cell Physiol, 2018, 233(6): 4926-4934., articleTitle=null, refAbstract=null), Reference(id=1329835615887143762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Anfray C, Mainini F, Digifico E, et al. Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity[J]. J Immunother Cancer, 2021, 9(9): e002408., articleTitle=null, refAbstract=null), Reference(id=1329835616017167187, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Meng X, Cui X, Shao X, et al. Poly (I: C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells[J]. Transl Oncol, 2022, 18: 101362., articleTitle=null, refAbstract=null), Reference(id=1329835616071693140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Xin B, Yang M, Wu P, et al. Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice[J]. Hepatology, 2022, 76(3): 630-645., articleTitle=null, refAbstract=null), Reference(id=1329835616147190613, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Tsan MF, Gao B. Endogenous ligands of Toll-like receptors[J]. J Leukoc Biol, 2004, 76(3): 514-519., articleTitle=null, refAbstract=null), Reference(id=1329835616214299478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Ribes S, Adam N, Ebert S, et al. The viral TLR3 agonist poly (I: C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cells[J]. Neurosci Lett, 2010, 482(1): 17-20., articleTitle=null, refAbstract=null), Reference(id=1329835616273019735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Pyles RB, Jezek GE, Eaves-Pyles TD. Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection[J]. Infect Immun, 2010, 78(4): 1700-1710., articleTitle=null, refAbstract=null), Reference(id=1329835616369488728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo C, Ye J, Song M, et al. PolyI: C promotes malate to enhance innate immune response against bacterial infection[J]. Fish Shellfish Immunol, 2022, 131: 172-180., articleTitle=null, refAbstract=null), Reference(id=1329835616440791897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Speth M, Repnik U, Griffiths G. Layer-by-layer nanocoating of live Bacille-Calmette-Guérin mycobacteria with poly (I: C) and chitosan enhances pro-inflammatory activation and bactericidal capacity in murine macrophages[J]. Biomaterials, 2016, 111: 1-12., articleTitle=null, refAbstract=null), Reference(id=1329835616503706458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Sadeghi Z, Fasihi-Ramandi M, Bouzari S. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with polyI: C against Brucella melitensis and Brucella abortus infection[J]. Int Immunopharmacol, 2019, 75: 105829., articleTitle=null, refAbstract=null), Reference(id=1329835616562426715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Golshani M, Amani M, Amirzadeh F, et al. Evaluation of poly (I: C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice[J]. Int Immunopharmacol, 2020, 84: 106573., articleTitle=null, refAbstract=null), Reference(id=1329835616633729884, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu W, Zhang Y, Zhang J, et al. Astragalus polysaccharides, chitosan and poly (I: C) obviously enhance inactivated Edwardsiella ictaluri vaccine potency in yellow catfish Pelteobagrus fulvidraco[J]. Fish Shellfish Immunol, 2019, 87: 379-385., articleTitle=null, refAbstract=null), Reference(id=1329835616709227357, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=De Waele J, Verhezen T, van der Heijden S, et al. A systematic review on poly (I: C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy[J]. J Exp Clin Cancer Res, 2021, 40(1): 213., articleTitle=null, refAbstract=null), Reference(id=1329835616793113438, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu J, Huang S, Zhao X, et al. Poly (I: C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model[J]. J Virol, 2014, 88(18): 10421-10431., articleTitle=null, refAbstract=null), Reference(id=1329835616889582431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Du Y, Yang X, Li J, et al. Delivery of toll-like receptor 3 ligand poly (I: C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model[J]. Acta Biomater, 2021, 133: 297-307., articleTitle=null, refAbstract=null), Reference(id=1329835616973468512, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Bardel E, Doucet-Ladeveze R, Mathieu C, et al. Intradermal immunisation using the TLR3-ligand poly (I: C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection[J]. NPJ vaccines, 2016, 1: 16010., articleTitle=null, refAbstract=null), Reference(id=1329835617040577377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=de Souza Apostólico J, Lunardelli VAS, Yamamoto MM, et al. Poly (I: C) potentiates T cell immunity to a dendritic cell targeted HIV-multiepitope vaccine[J]. Front Immunol, 2019, 10: 843., articleTitle=null, refAbstract=null), Reference(id=1329835617107686242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Sabbaghi A, Malek M, Abdolahi S, et al. A formulated poly (I: C)/CCL21 as an effective mucosal adjuvant for γ-irradiated influenza vaccine[J]. Virol J, 2021, 18(1): 201., articleTitle=null, refAbstract=null), Reference(id=1329835617162212195, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=Dos-Santos JS, Firmino-Cruz L, da Fonseca-Martins AM, et al. Immunogenicity of SARS-CoV-2 trimeric spike protein associated to poly (I: C) plus alum[J]. Front Immunol, 2022, 13: 884760., articleTitle=null, refAbstract=null), Reference(id=1329835617237709668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=Renu S, Feliciano-Ruiz N, Lu F, et al. A nanoparticle-poly (I: C) combination adjuvant enhances the breadth of the immune response to inactivated influenza virus vaccine in pigs[J]. Vaccines, 2020, 8(2): 229., articleTitle=null, refAbstract=null), Reference(id=1329835617329984357, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=Lysén A, Gudjonsson A, Tesfaye D, et al.[J]. Scand J Immunol, 2022, 95(3): e13128., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329835607502730026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, awardId=ZYXY21003, language=CN, fundingSource=四川大学华西医院学科卓越发展135工程项目(ZYXY21003), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.11.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.11.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.11.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.11.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1699545600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
聚肌胞苷酸在免疫制剂中的研究进展
柯丁心 , 王毅 , 孙敏 , 蒋亚君 , 刘开云 *
世界临床药物 | 综述评论 2023,44(11): 1219-1225
收起
收藏切换
世界临床药物 |综述评论 2023 , 44 (11) : 1219 -1225
聚肌胞苷酸在免疫制剂中的研究进展
全屏
[Author(id=1329835603983708938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835604059206412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835603983708938, language=EN, stringName=Dingxin KE, firstName=Dingxin, middleName=null, lastName=KE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835604151481101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835603983708938, language=CN, stringName=柯丁心, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio={"content":"

柯丁心,助理实验师,研究方向:幽门螺杆菌疫苗的研究。

"}, bioImg=null, bioContent=

柯丁心,助理实验师,研究方向:幽门螺杆菌疫苗的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835604239561487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835604344419089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835604239561487, language=EN, stringName=Yi WANG, firstName=Yi, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835604419916562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835604239561487, language=CN, stringName=王毅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835606068278036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835606181524246, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606068278036, language=EN, stringName=Min SUN, firstName=Min, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835606311547671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606068278036, language=CN, stringName=孙敏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835606387045145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835606504485659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606387045145, language=EN, stringName=Yajun JIANG, firstName=Yajun, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835606592566044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606387045145, language=CN, stringName=蒋亚君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])]), Author(id=1329835606672257822, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835606747755296, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606672257822, language=EN, stringName=Kaiyun LIU, firstName=Kaiyun, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835606840029985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, authorId=1329835606672257822, language=CN, stringName=刘开云, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=四川大学华西医院生物制药研究院,四川 成都 610044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835603866268422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, xref=null, ext=[AuthorCompanyExt(id=1329835603874657031, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China), AuthorCompanyExt(id=1329835603899822856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835603128070915, companyId=1329835603866268422, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=四川大学华西医院生物制药研究院,四川 成都 610044)])])]
柯丁心, 王毅, 孙敏, 蒋亚君, 刘开云*
作者信息
  • 四川大学华西医院生物制药研究院,四川 成都 610044
通讯作者:
刘开云,副教授,研究方向:细菌感染免疫机制与创新疫苗研究。
作者简介:

柯丁心,助理实验师,研究方向:幽门螺杆菌疫苗的研究。

Research progress of polyinosinic polycytidylic acid in immunopreparations
Dingxin KE, Yi WANG, Min SUN, Yajun JIANG, Kaiyun LIU*
Affiliations
  • Institute of Biopharmacy, West China Hospital, Sichuan University, Chengdu 610044, Sichuan Province, China
出版时间: 2023-11-10 doi: 10.13683/j.wph.2023.11.016
文章导航
收藏切换

聚肌胞苷酸是一种人工合成的双链核糖核酸,可被Toll样受体3识别,诱导先天和适应性免疫反应,其通常被认为是一种Ⅰ型干扰素诱导剂、抗病毒和抗肿瘤等免疫调节剂,也是有效的疫苗佐剂,并在疾病治疗中展现出巨大的潜力。因此该文从聚肌胞苷酸的作用机制、安全性及在临床中作为免疫制剂的研究进展等方面进行综述,希望能为其的后续研究提供有益参考。

聚肌胞苷酸  /  Toll样受体3  /  免疫治疗  /  疫苗佐剂

Polyinosinic polycytidylic acid is an artificially synthesized double stranded ribonucleic acid that is recognized by Toll-like receptor 3, induces innate and adaptive immune responses. It is generally considered as a type Ⅰinterferon inducer, antiviral and anti-tumor immunomodulator agent, and also an effective vaccine adjuvant, and has shown great potential in the treatment of diseases. Therefore, this article reviewed the regulatory mechanism, safety, and the research progress of polyinosinic polycytidylic acid as an immunologic agent in clinical practice, hoping to provide useful reference for the follow-up research of polyinosinic polycytidylic acid.

polyinosinic polycytidylic acid  /  Toll-like receptor 3  /  immunotherapy  /  vaccine adjuvant
柯丁心, 王毅, 孙敏, 蒋亚君, 刘开云. 聚肌胞苷酸在免疫制剂中的研究进展. 世界临床药物, 2023 , 44 (11) : 1219 -1225 . DOI: 10.13683/j.wph.2023.11.016
Dingxin KE, Yi WANG, Min SUN, Yajun JIANG, Kaiyun LIU. Research progress of polyinosinic polycytidylic acid in immunopreparations[J]. World Clinical Drug, 2023 , 44 (11) : 1219 -1225 . DOI: 10.13683/j.wph.2023.11.016
  • 四川大学华西医院学科卓越发展135工程项目(ZYXY21003)
参考文献 引证文献
排序方式:
[1]
Field AK, Tytell AA, Lampson GP, et al. Inducers of interferon and host resistance. Ⅱ. Multistranded synthetic polynucleotide complexes[J]. Proc Natl Acad Sci U S A, 1967, 58(3): 1004-1010.
[2]
Hong Y, Lee J, Vu TH, et al. Immunomodulatory effects of poly (I: C)-stimulated exosomes derived from chicken macrophages[J]. Poult Sci, 2021, 100(8): 101247.
[3]
Haddad FL, Patel SV, Schmid S. Maternal immune activation by polyI: C as a preclinical model for neurodevelopmental disorders: a focus on autism and schizophrenia[J]. Neurosci Biobehav Rev, 2020, 113: 546-567.
[4]
Chen Y, Lin J, Zhao Y, et al. Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses[J]. J Zhejiang Univ Sci B, 2021, 22(8): 609-632.
[5]
Hafner AM, Corthesy B, Merkle HP. Particulate formulations for the delivery of poly (I: C) as vaccine adjuvant[J]. Adv Drug Deliv Rev, 2013, 65(10): 1386-1399.
[6]
Yu M, Levine SJ. Toll-like receptor, RIG-Ⅰ-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses[J]. Cytokine Growth Factor Rev, 2011, 22(2): 63-72.
[7]
Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination[J]. Nat Rev Immunol, 2012, 12(7): 479-491.
[8]
Sultan H, Salazar AM, Celis E. Poly-ICLC, a multi-functional immune modulator for treating cancer[J]. Semin Immunol, 2020, 49: 101414.
[9]
Mori H, Murakami M, Tsuda T, et al. Reduced-HMGB1 suppresses poly (I: C)-induced inflammation in keratinocytes[J]. J Dermatol Sci, 2018, 90(2): 154-165.
[10]
De Waele J, Verhezen T, van der Heijden S, et al. A systematic review on poly (I: C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy[J]. J Exp Clin Cancer Res, 2021, 40(1): 213.
[11]
Komal A, Noreen M, El-Kott AF. TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review[J]. Immunol Res, 2021, 69(4): 312-322.
[12]
Gitlin L, Barchet W, Gilfillan S, et al. Essential role of MDA-5 in type Ⅰ IFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus[J]. Proc Natl Acad Sci U S A, 2006, 103(22): 8459-8464.
[13]
Sultan H, Wu J, Fesenkova VI, et al. Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration[J]. J Immunother Cancer, 2020, 8(2): e001224.
[14]
Fučíková J, Rožková D, Ulčová H, et al. PolyI: C-activated dendritic cells that were generated in Cellgro for use in cancer immunotherapy trials[J]. J Transl Med, 2011, 9: 223.
[15]
Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation[J]. J Clin Investigation, 2007, 117(5): 1119-1127.
[16]
Sultan H, Wu J, Kumai T, et al. Role of MDA5 and interferon-Ⅰ in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice[J]. Cancer Immunol Immunother, 2018, 67(7): 1091-1103.
[17]
Plote D, Choi W, Mokkapati S, et al. Inhibition of urothelial carcinoma through targeted type Ⅰ interferon-mediated immune activation[J]. Oncoimmunology, 2019, 8(5): e1577125.
[18]
Anfray C, Mainini F, Digifico E, et al. Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity[J]. J Immunother Cancer, 2021, 9(9): e002408.
[19]
Le Naour J, Galluzzi L, Zitvogel L, et al. Trial watch: TLR3 agonists in cancer therapy[J]. Oncoimmunology, 2020, 9(1): 1771143.
[20]
Matsumoto M, Takeda Y, Seya T. Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy[J]. Expert Opin Biol Ther, 2020, 20(8): 937-946.
[21]
Martins KAO, Bavari S, Salazar AM. Vaccine adjuvant uses of poly-IC and derivatives[J]. Expert Rev Vaccines, 2015, 14(3): 447-459.
[22]
Kato H, Takeuchi O, Mikamo-Satoh E, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-Ⅰ and melanoma differentiation-associated gene 5[J]. J Exp Med, 2008, 205(7): 1601-1610.
[23]
Bumcrot D, Manoharan M, Koteliansky V, et al. RNAi therapeutics: a potential new class of pharmaceutical drugs[J]. Nat Chem Biol, 2006, 2(12): 711-719.
[24]
Aranda F, Vacchelli E, Obrist F, et al. Trial watch: Toll-like receptor agonists in oncological indications[J]. Oncoimmunology, 2014, 3: e29179.
[25]
Krown SE, Kerr D, Stewart WE, et al. Phase Ⅰ trials of poly (I, C) complexes in advanced cancer[J]. J Biol Response Mod, 1985, 4(6): 640-649.
[26]
Ko KH, Cha SB, Lee SH, et al. A novel defined TLR3 agonist as an effective vaccine adjuvant[J]. Front Immunol, 2023, 14: 1075291.
[27]
Ammi R, de Waele J, Willemen Y, et al. Poly (I: C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs[J]. Pharmacol Ther, 2015, 146: 120-131.
[28]
Chin AI, Miyahira AK, Covarrubias A, et al. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance[J]. Cancer Res, 2010, 70(7): 2595-2603.
[29]
Kawai T, Akira S. Toll-like receptor and RIG-Ⅰ-like receptor signaling[J]. Ann N Y Acad Sci, 2008, 1143: 1-20.
[30]
Besch R, Poeck H, Hohenauer T, et al. Proapoptotic signaling induced by RIG-Ⅰ and MDA-5 results in type Ⅰ interferon-independent apoptosis in human melanoma cells[J]. J Clinical Investigation, 2009, 119(8): 2399-2411.
[31]
Guinn ZP, Petro TM. IFN-γ synergism with poly I: C reduces growth of murine and human cancer cells with simultaneous changes in cell cycle and immune checkpoint proteins[J]. Cancer Lett, 2018, 438: 1-9.
[32]
Zheng X, Li S, Yang H. Roles of Toll-like receptor 3 in human tumors[J]. Front Immunol, 2021, 12: 667454.
[33]
TIssari J, Sirén J, Meri S, et al. IFN-α enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression[J]. J Immunol, 2005, 174(7): 4289-4294.
[34]
Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-Ⅰ has an essential function in double-stranded RNA-induced innate antiviral responses[J]. Nat Immunol, 2004, 5(7): 730-737.
[35]
Aznar MA, Planelles L, Perez-Olivares M, et al. Immunotherapeutic effects of intratumoral nanoplexed poly I: C[J]. J Immunother Cancer, 2019, 7(1): 116.
[36]
Márquez-Rodas I, Longo F, Rodriguez-Ruiz ME, et al. Intratumoral nanoplexed poly I: C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors[J]. Sci Transl Med, 2020, 12(565): eabb0391.
[37]
Penza V, Russell S, Schulze AJ. The long-lasting enigma of polycytidine (polyC) tract[J]. PLoS Pathog, 2021, 17(8): e1009739.
[38]
Liu X, Meng L, Chen L, et al. IL-6 expression promoted by poly (I: C) in cervical cancer cells regulates cytokine expression and recruitment of macrophages[J]. J Cell Mol Med, 2020, 24(3): 2284-2293.
[39]
Jiang X, Guan S, Qiao Y, et al. Effects of poly (I: C) and MF59 co-adjuvants on immunogenicity and efficacy of survivin polypeptide immunogen against melanoma[J]. J Cell Physiol, 2018, 233(6): 4926-4934.
[40]
Anfray C, Mainini F, Digifico E, et al. Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity[J]. J Immunother Cancer, 2021, 9(9): e002408.
[41]
Meng X, Cui X, Shao X, et al. Poly (I: C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells[J]. Transl Oncol, 2022, 18: 101362.
[42]
Xin B, Yang M, Wu P, et al. Enhancing the therapeutic efficacy of programmed death ligand 1 antibody for metastasized liver cancer by overcoming hepatic immunotolerance in mice[J]. Hepatology, 2022, 76(3): 630-645.
[43]
Tsan MF, Gao B. Endogenous ligands of Toll-like receptors[J]. J Leukoc Biol, 2004, 76(3): 514-519.
[44]
Ribes S, Adam N, Ebert S, et al. The viral TLR3 agonist poly (I: C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cells[J]. Neurosci Lett, 2010, 482(1): 17-20.
[45]
Pyles RB, Jezek GE, Eaves-Pyles TD. Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection[J]. Infect Immun, 2010, 78(4): 1700-1710.
[46]
Guo C, Ye J, Song M, et al. PolyI: C promotes malate to enhance innate immune response against bacterial infection[J]. Fish Shellfish Immunol, 2022, 131: 172-180.
[47]
Speth M, Repnik U, Griffiths G. Layer-by-layer nanocoating of live Bacille-Calmette-Guérin mycobacteria with poly (I: C) and chitosan enhances pro-inflammatory activation and bactericidal capacity in murine macrophages[J]. Biomaterials, 2016, 111: 1-12.
[48]
Sadeghi Z, Fasihi-Ramandi M, Bouzari S. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with polyI: C against Brucella melitensis and Brucella abortus infection[J]. Int Immunopharmacol, 2019, 75: 105829.
[49]
Golshani M, Amani M, Amirzadeh F, et al. Evaluation of poly (I: C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice[J]. Int Immunopharmacol, 2020, 84: 106573.
[50]
Zhu W, Zhang Y, Zhang J, et al. Astragalus polysaccharides, chitosan and poly (I: C) obviously enhance inactivated Edwardsiella ictaluri vaccine potency in yellow catfish Pelteobagrus fulvidraco[J]. Fish Shellfish Immunol, 2019, 87: 379-385.
[51]
De Waele J, Verhezen T, van der Heijden S, et al. A systematic review on poly (I: C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy[J]. J Exp Clin Cancer Res, 2021, 40(1): 213.
[52]
Wu J, Huang S, Zhao X, et al. Poly (I: C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model[J]. J Virol, 2014, 88(18): 10421-10431.
[53]
Du Y, Yang X, Li J, et al. Delivery of toll-like receptor 3 ligand poly (I: C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model[J]. Acta Biomater, 2021, 133: 297-307.
[54]
Bardel E, Doucet-Ladeveze R, Mathieu C, et al. Intradermal immunisation using the TLR3-ligand poly (I: C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection[J]. NPJ vaccines, 2016, 1: 16010.
[55]
de Souza Apostólico J, Lunardelli VAS, Yamamoto MM, et al. Poly (I: C) potentiates T cell immunity to a dendritic cell targeted HIV-multiepitope vaccine[J]. Front Immunol, 2019, 10: 843.
[56]
Sabbaghi A, Malek M, Abdolahi S, et al. A formulated poly (I: C)/CCL21 as an effective mucosal adjuvant for γ-irradiated influenza vaccine[J]. Virol J, 2021, 18(1): 201.
[57]
Dos-Santos JS, Firmino-Cruz L, da Fonseca-Martins AM, et al. Immunogenicity of SARS-CoV-2 trimeric spike protein associated to poly (I: C) plus alum[J]. Front Immunol, 2022, 13: 884760.
[58]
Renu S, Feliciano-Ruiz N, Lu F, et al. A nanoparticle-poly (I: C) combination adjuvant enhances the breadth of the immune response to inactivated influenza virus vaccine in pigs[J]. Vaccines, 2020, 8(2): 229.
[59]
Lysén A, Gudjonsson A, Tesfaye D, et al.[J]. Scand J Immunol, 2022, 95(3): e13128.
2023年第44卷第11期
16
5
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.11.016
  • 接收时间:2023-01-29
  • 首发时间:2026-11-18
  • 出版时间:2023-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-01-29
基金
四川大学华西医院学科卓越发展135工程项目(ZYXY21003)
作者信息
    四川大学华西医院生物制药研究院,四川 成都 610044

通讯作者:

刘开云,副教授,研究方向:细菌感染免疫机制与创新疫苗研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.11.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏